Advertisement

Topics

STAT Plus: ‘Beyond amyloid’: A look at what’s next in Alzheimer’s research

04:30 EDT 18 Aug 2017 | STAT

A parade of failed clinical trials has stoked new research efforts, as the field in general and its pharma colleagues think beyond amyloid hypothesis.

Original Article: STAT Plus: ‘Beyond amyloid’: A look at what’s next in Alzheimer’s research

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: ‘Beyond amyloid’: A look at what’s next in Alzheimer’s research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...